InvestorsHub Logo
Followers 33
Posts 1622
Boards Moderated 0
Alias Born 10/06/2015

Re: B52T38 post# 190783

Saturday, 10/23/2021 2:20:05 AM

Saturday, October 23, 2021 2:20:05 AM

Post# of 233052
Agreed - Approval and use of surprisingly safe Leronlimab could turn the Covid-19 from a killer to an inconvenience.

Upon positive result to covid-19 test (variant DOESN"T matter), begin with first 700 mg SubC injection, then one injection a week for four weeks. Can return to work when tests negative for virus, but should complete all four shots.

Some residual Covid results could manifest as time goes by necessitating another short course of Leronlimab injection(s).

Hardly anybody dies (from the covid or covid - immunological effects)

Relieves pressure on the medical institutions.

Life goes on

The "state" stays OPEN

IMO

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News